Results 41 to 50 of about 20,538 (302)
Review: Diagnosis and treatment of paroxysmal dyskinesias revisited
Therapeutic Advances in Neurological Disorders, 2008 Paroxysmal dyskinesias (PDs) are a rare group of hyperkinetic movement disorders mainly characterized by their episodic nature. Neurological examination may be entirely normal between the attacks.
Iris Unterberger, Eugen Trinka
doaj +1 more source
Opsoclonus-Myoclonus and Streptococcal Infection
Pediatric Neurology Briefs, 2007 A 9-year-old Nepalese boy living in the UK presented with opsoclonus-myoclonus syndrome associated with group A streptococcal infection, and is reported from St Mary's Hospital, London; and University of Southampton, UK.
J Gordon Millichap
doaj +1 more source
Doxycycline to treat levodopa-induced dyskinesias in Parkinson's disease: a preliminary study
Arquivos de Neuro-Psiquiatria, 2023 Background Levodopa-induced dyskinesia (LID) is a common motor complication of levodopa therapy in patients with Parkinson's disease (PD). Doxycycline is a widely used and inexpensive tetracycline with anti-inflammatory properties.
Bruno Lopes Santos-Lobato +5 more
doaj +1 more source
Dopamine dysregulation in a mouse model of paroxysmal nonkinesigenic dyskinesia. [PDF]
, 2012 Paroxysmal nonkinesigenic dyskinesia (PNKD) is an autosomal dominant episodic movement disorder. Patients have episodes that last 1 to 4 hours and are precipitated by alcohol, coffee, and stress.
Edwards, Robert H +10 more
core +2 more sources
Levodopa Effect and Motor Function in Late Stage Parkinson’s Disease
Journal of Parkinson’s Disease, 2018 Background: It is unclear to which degree Levodopa (L-dopa) remains effective also in the late stage of Parkinson’s disease (PD) and to which degree motor fluctuations and dyskinesias remain a problem.
Kristina Rosqvist +5 more
doaj +1 more source
Phenobarbital dyskinesia [PDF]
Postgraduate Medical Journal, 1978 Summary A patient was admitted to hospital following an overdose of phenobarbital. During her recovery she developed both chorea and torsion dystonia which could only be related to her high plasma phenobarbital levels.
openaire +2 more sources
FDG‐PET Associations With Disease Severity and Outcomes in NMDA‐Receptor IgG Autoimmune Encephalitis
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Background Patients with N‐methyl‐D‐aspartate (NMDA) receptor‐immunoglobulin G (IgG) autoimmune encephalitis (NMDAR‐IgG AE) demonstrate occipital lobe hypometabolism on baseline brain fluorodeoxyglucose‐positron emission tomography (bFDG‐PET).
Jonathan K. Lee +7 more
wiley +1 more source
From the "Jumpers in Maine" to the ‘Boy from Paris’: The life of Georges Gilles de la Tourette and the first description of tic disease [PDF]
Vojnosanitetski PregledIn 1885, French neuropsychiatrist Dr. Georges Gilles de la Tourette was the first to describe a disease of tics. His success was not unexpected, as he was a student of the renowned neurologist Dr. Jean-Martin Charcot.
Damjanović Radomir +3 more
doaj +1 more source
CSF Monoamine Metabolites and Cognitive Trajectory in Early Parkinson's Disease
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Background Imaging and postmortem studies indicate that abnormalities in monoaminergic neurotransmission contribute to cognitive impairment in Parkinson's disease (PD). However, it remains uncertain if cerebrospinal fluid (CSF) monoamine metabolites can serve as biomarkers of cognitive decline in early PD.
Jing‐Yu Shao +7 more
wiley +1 more source
PLoS ONE, 2013 The development of dyskinesias following chronic L-DOPA replacement therapy remains a major problem in the long-term treatment of Parkinson's disease.
Romina Aron Badin +14 more
doaj +1 more source